Last reviewed 2026-04-23 · How we verify

BEBT-209 Placebo capluses

This is a placebo formulation with no active pharmacological mechanism.

At a glance

Mechanism of action

BEBT-209 Placebo capsules contain no active pharmaceutical ingredient and serve as a control comparator in clinical trials. Placebo formulations are used to establish the baseline effect of the disease, natural history, and investigator/patient bias in phase 3 randomized controlled trials.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.